Thymoglobulin
(Anti-Thymocyte Globulin)
Manufacturer: Sanofi-Aventis
General Information: Thymoglobulin
is typically utilized for the treatment of renal transplant acute
rejection in conjunction with concomitant immunosuppression. For indications, dosing and other information, please refer
to the manufacture package insert. |
| |
|
Manufacturer |
Product |
Size |
NDC Number |
PI |
MSDS |
| Genzyme |
Thymoglobulin |
25 mg |
58468-0080-01 |
PI |
MSDS |
| |
|
|
|
|
|
|
| Clinical
Data: For any questions
or for further information
related to Thymoglobulin, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |